Shenzhen, China (Newsfile Corp. - April 28, 2023) - Recently, Kexing Biopharm (688136.SH) has completed the first dose of its long-acting GC product, Pegylated Human Granulocyte Colony-stimulating Factor
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.
Chinese pharmaceutical enterprises are ramping up efforts to expand business in Southeast Asia to take advantage of favorable regulatory approval policies and mounting market opportunities.
Domestic pharmas expand in SE Asia--China Economic Net en.ce.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from en.ce.cn Daily Mail and Mail on Sunday newspapers.